サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566758

網膜硝子体手術装置市場：製品タイプ別、手術タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Vitreoretinal Surgery Devices Market By Product , By Surgery Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
網膜硝子体手術装置市場：製品タイプ別、手術タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

網膜硝子体手術装置

網膜硝子体手術装置市場は、2023年に23億米ドルと評価され、2024～2033年にかけてCAGR 5.9%で成長し、2033年には41億米ドルに達すると予測されています。

網膜硝子体手術装置は、目の網膜や硝子体に焦点を当てた眼科手術を行うために不可欠な専門装置です。黄斑円孔、網膜剥離、糖尿病網膜症、網膜上膜などの多様な網膜疾患は、眼球の正常な解剖学的構造と機能を修復・回復するためにこれらの装置を使用して治療されます。装置の革新により、最小限の侵襲で手術を行うことができるため、回復時間が短縮され、患者の転帰が改善されます。

特に高齢者の間で眼科手術の普及率が高まっていることが、網膜硝子体手術装置市場の主要な促進要因となっています。さらに、医療施設に対する政府の支出増加が網膜硝子体手術装置の進歩につながり、医療現場での採用を後押ししています。現在、ロボット技術の手術装置への統合が市場の新たな動向となっています。この技術は、このような複雑な手術において人間の技術を凌駕し、ミスの可能性を減らし、精度を高めています。研究者たちは、ロボット工学とAIの融合によって、スマートな外科手術を実現することを目指しています。

しかし、網膜硝子体手術装置を調達するための高額な初期費用や、メンテナンスの必要性が、小規模な医療施設に投資を思いとどまらせています。このことが、様々な新興国や十分なサービスを受けていない地域における市場の成長を抑制しています。対照的に、眼疾患の数は絶えず増加しており、将来的に網膜硝子体手術装置の採用を後押しすると予測されています。Bright Focus Foundationが2022年10月に発表したファクトシートによると、米国では約1,100万人が何らかの加齢黄斑変性に苦しんでいます。同財団は、この数は2050年までに2倍の2,200万人近くにまで増加すると予想しており、それゆえ治療用器具の使用を余儀なくされています。

セグメントのレビュー

網膜硝子体手術装置市場は、製品、手術タイプ、エンドユーザー、地域に区分されます。製品ベースでは、市場はパーフルオロカーボン液、内照器具、網膜硝子体プレフィルドシリコーンオイルシリンジ、硝子体手術システム、その他に分けられます。手術タイプに基づき、市場は網膜前部部硝子体手術と網膜後部硝子体手術に二分されます。エンドユーザー別では、病院、専門クリニック、外来手術センターに分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

製品別では、硝子体手術システムセグメントが2023年の市場を独占しました。

手術タイプ別では、網膜前部硝子体手術セグメントが2023年の市場で高いシェアを獲得しました。

エンドユーザー別では、病院セグメントが2023年に高い市場シェアを占めました。

地域別では、北米が2023年に最も高い収益を上げました。

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 網膜硝子体手術装置市場：製品別

  • 市場概要
  • パーフルオロカーボン液体
  • 内照式器具
  • 網膜硝子体用プレフィルドシリコーンオイルシリンジ
  • 硝子体手術システム
  • その他

第5章 網膜硝子体手術装置市場：手術タイプ別

  • 市場概要
  • 網膜前部硝子体手術
  • 網膜後部硝子体手術

第6章 網膜硝子体手術装置市場：エンドユーザー別

  • 市場概要
  • 病院
  • 専門クリニック
  • 外来手術センター

第7章 血管外科用装置市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の網膜硝子体手術装置市場
    • カナダの網膜硝子体手術装置市場
    • メキシコの網膜硝子体手術装置市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの網膜硝子体手術装置市場
    • フランスの網膜硝子体手術装置市場
    • 英国の網膜硝子体手術装置市場
    • イタリアの網膜硝子体手術装置市場
    • スペインの網膜硝子体手術装置市場
    • その他の欧州の網膜硝子体手術装置市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本の網膜硝子体手術装置市場
    • 中国の網膜硝子体手術装置市場
    • オーストラリアの網膜硝子体手術装置市場
    • インドの網膜硝子体手術装置市場
    • 韓国の網膜硝子体手術装置市場
    • その他のアジア太平洋の網膜硝子体手術装置市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの網膜硝子体手術装置市場
    • サウジアラビアの網膜硝子体手術装置市場
    • 南アフリカの網膜硝子体手術装置市場
    • その他のラテンアメリカ・中東・アフリカの網膜硝子体手術装置市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Bausch And Lomb
  • Novartis AG
  • Inami And Co
  • Paragon Care Group Pty Ltd
  • Oculus Inc
  • MedOne Surgical, Inc
  • Carl Zeiss Meditec AG
  • Peregrine Surgical
  • Johnson And Johnson
  • Blink Medical
目次
Product Code: A00914

Vitreoretinal Surgery Devices

The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Perfluorocarbon Liquids
  • Endoillumination Instrument
  • Vitreoretinal Prefilled Silicone Oil Syringes
  • Vitrectomy System
  • Other

By Surgery Type

  • Anterior Vitreoretinal Surgery
  • Posterior Vitreoretinal Surgery

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Bausch & Lomb
    • Novartis AG
    • Inami & Co
    • Paragon Care Group Pty Ltd
    • Oculus Inc
    • MedOne Surgical, Inc
    • Carl Zeiss Meditec AG
    • Peregrine Surgical
    • Johnson & Johnson
    • Blink Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Perfluorocarbon Liquids
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Endoillumination Instrument
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Vitreoretinal Prefilled Silicone Oil Syringes
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Vitrectomy System
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Other
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Surgery Type
  • 5.2. Anterior Vitreoretinal Surgery
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Posterior Vitreoretinal Surgery
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Surgery Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Vitreoretinal Surgery Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Surgery Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Vitreoretinal Surgery Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Surgery Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Vitreoretinal Surgery Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Surgery Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Surgery Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Vitreoretinal Surgery Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Surgery Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Vitreoretinal Surgery Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Surgery Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Vitreoretinal Surgery Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Surgery Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Vitreoretinal Surgery Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Surgery Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Vitreoretinal Surgery Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Surgery Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Surgery Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Surgery Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Vitreoretinal Surgery Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Surgery Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Vitreoretinal Surgery Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Surgery Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Vitreoretinal Surgery Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Surgery Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Vitreoretinal Surgery Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Surgery Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Vitreoretinal Surgery Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Surgery Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Surgery Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Surgery Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Vitreoretinal Surgery Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Surgery Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Surgery Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Vitreoretinal Surgery Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Surgery Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Surgery Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Bausch And Lomb
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Inami And Co
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Paragon Care Group Pty Ltd
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Oculus Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. MedOne Surgical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Carl Zeiss Meditec AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Peregrine Surgical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Johnson And Johnson
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Blink Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments